Measles Virus by A/Prof David S. Goodsell, RCSB Protein Data Bank; SARS-CoV-2 virus by Ms Alissa Eckert Dan Higgins, MAM/CDC / Science Source; Rhinocladiella mackenziei by Dr Shawn Vasoo, NCID; Plasmodium falciparum by A/Prof Yeo Tsin Wen, LKCM.
In children, rubella is usually mild with low-grade fever, nausea, rash, swollen neck lymph glands and eye redness. But infection in a pregnant woman (especially during the first trimester) can result in congenital rubella syndrome, with miscarriage, premature delivery and birth defects in the baby such as deafness, heart problems, and developmental delays.
Women can avoid the the risk of rubella and its complications in babies by getting vaccinated before pregnancy. MMR (Measles, Mumps, Rubella) vaccine is part of Singapore National Childhood Immunisation Programme (NCIP); the first dose is recommended at 12 months of age and the second dose at 15-18 months of age.
Earlier reports of links between the MMR vaccine and autism, chronic arthritis and other chronic conditions have been discredited, and found to have no scientific basis.
However, MMR vaccine is a live vaccine, made from weakened viruses so that individuals can be protected against the actual virus if they are ever exposed. This protection is lifelong. Side effects of the vaccine are mild and may consist of low-grade fever. Rash and joint aches can occur but are uncommon.
If your child’s caregivers have never received 2 doses of MMR vaccine, if infected, they can transmit rubella to an infant who has not yet been protected by MMR vaccine.
ASK YOUR DOCTOR about MMR for your children, and also for their caregivers.
PRECAUTION: MMR is a live virus vaccine. Women who are pregnant, and persons with serious immune system problems generally should NOT receive live vaccines.
By Dr Lee Tau Hong – Head, Antimicrobial Resistance Coordinating Office
Visit a Specialist
Getting to NCID
Facilities & Services
Cost & Financing
Patients’ Rights & Responsibilities
Diseases and Conditions
Infection Control Guidelines for Healthcare Facilities
Resources on COVID-19
Updates on the HIV/AIDS Situation in Singapore
Joint MOH/ NCID Guidances
Communicable Diseases Surveillance in Singapore
NCID Research Publications
Weekly Infectious Diseases Bulletin
Opinion Pieces by NCID Experts
Grants and Fellowships
FAQs on COVID-19
NCID Research Studies
3 Decades of HIV Treatment and Care at the Communicable Disease Centre
List of Funeral Service Companies Trained in Basic Infection Control Course (BICC)
NCID’s Response to COVID-19
The NCID Gallery
Scientific Research Advisory Board
Research Output Analysis
Directory of Experts
News & Events